G0S2 and type 2 diabetes mellitus: In patients with type 2 diabetes mellitus on insulin treatment, ATGL protein was borderline increased in subcutaneous adipose tissue, and G0S2 mRNA and protein were decreased when insulin treatment was withheld and patients were hyperglycaemic [23].